Companies
Muhdo
a UK epigenetics company whose supplement range is informed by data from 70,000 individuals and which publishes gene-level skin-health material, representing the methylation-based rather than genotype-based end of the same market.
- Country
- United Kingdom
EU
Coverage
| EU | IN | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaemaftc
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| DNA-personalized skincare | specialty-fine-chem | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.